Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease

By sjmartinez • December 23, 2024

Volkmann ER, Wilhalme H, Tashkin DP, Kim GHJ, Goldin J, Haussmann A, Kuwana M, Roth MD, Assassi S. Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease. Arthritis Care Res (Hoboken). 2024 Dec 22. doi: 10.1002/acr.25485. Epub ahead of print. PMID: 39711034.

Tags: DOM STAT, General Internal Medicine, Publications, Pulmonary, Critical Care & Sleep Medicine, Rheumatology

Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium

Nguyen T, Koric A, Chang CE, Barul C, Radoi L, Serraino D, Purdue MP, Kelsey KT, McClean MD, Negri E, Edefonti V, Moysich K, Zhang[...]

Small Molecules, Big Results: How JAK Inhibitors Have Transformed the Treatment of Patients with

Fansiwala K, Sauk JS. Small Molecules, Big Results: How JAK Inhibitors Have Transformed the Treatment of Patients with IBD. Dig Dis Sci. 2024 Dec 20.[...]

Pharmacoequity measurement framework: A tool to reduce health disparities

Patel PM, Essien UR, Happe L. Pharmacoequity measurement framework: A tool to reduce health disparities. J Manag Care Spec Pharm. 2024 Dec 20:1-11. doi: 10.18553/jmcp.2025.24298.[...]